nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Localized exfoliation—Triamcinolone—psoriatic arthritis	0.0593	0.0593	CcSEcCtD
Vildagliptin—Blister—Prednisolone—psoriatic arthritis	0.0241	0.0241	CcSEcCtD
Vildagliptin—Flatulence—Auranofin—psoriatic arthritis	0.0235	0.0235	CcSEcCtD
Vildagliptin—Blister—Triamcinolone—psoriatic arthritis	0.0222	0.0222	CcSEcCtD
Vildagliptin—Angioedema—Auranofin—psoriatic arthritis	0.0218	0.0218	CcSEcCtD
Vildagliptin—Blister—Dexamethasone—psoriatic arthritis	0.0201	0.0201	CcSEcCtD
Vildagliptin—Blister—Betamethasone—psoriatic arthritis	0.0201	0.0201	CcSEcCtD
Vildagliptin—Constipation—Auranofin—psoriatic arthritis	0.0166	0.0166	CcSEcCtD
Vildagliptin—Urticaria—Auranofin—psoriatic arthritis	0.0154	0.0154	CcSEcCtD
Vildagliptin—Skin exfoliation—Triamcinolone—psoriatic arthritis	0.0152	0.0152	CcSEcCtD
Vildagliptin—Skin exfoliation—Methylprednisolone—psoriatic arthritis	0.0152	0.0152	CcSEcCtD
Vildagliptin—Skin exfoliation—Dexamethasone—psoriatic arthritis	0.0138	0.0138	CcSEcCtD
Vildagliptin—Skin exfoliation—Betamethasone—psoriatic arthritis	0.0138	0.0138	CcSEcCtD
Vildagliptin—Diarrhoea—Auranofin—psoriatic arthritis	0.0133	0.0133	CcSEcCtD
Vildagliptin—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.0132	0.0132	CcSEcCtD
Vildagliptin—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.0121	0.0121	CcSEcCtD
Vildagliptin—Skin exfoliation—Prednisone—psoriatic arthritis	0.012	0.012	CcSEcCtD
Vildagliptin—Nausea—Auranofin—psoriatic arthritis	0.0115	0.0115	CcSEcCtD
Vildagliptin—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.011	0.011	CcSEcCtD
Vildagliptin—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.011	0.011	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisolone—psoriatic arthritis	0.0107	0.0107	CcSEcCtD
Vildagliptin—Skin exfoliation—Methotrexate—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Vildagliptin—Weight increased—Prednisolone—psoriatic arthritis	0.00991	0.00991	CcSEcCtD
Vildagliptin—Pancreatitis—Triamcinolone—psoriatic arthritis	0.00982	0.00982	CcSEcCtD
Vildagliptin—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.0098	0.0098	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00931	0.00931	CcSEcCtD
Vildagliptin—Weight increased—Triamcinolone—psoriatic arthritis	0.00912	0.00912	CcSEcCtD
Vildagliptin—Weight increased—Methylprednisolone—psoriatic arthritis	0.0091	0.0091	CcSEcCtD
Vildagliptin—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00891	0.00891	CcSEcCtD
Vildagliptin—Infestation—Methylprednisolone—psoriatic arthritis	0.00891	0.00891	CcSEcCtD
Vildagliptin—Weight increased—Dexamethasone—psoriatic arthritis	0.00827	0.00827	CcSEcCtD
Vildagliptin—Weight increased—Betamethasone—psoriatic arthritis	0.00827	0.00827	CcSEcCtD
Vildagliptin—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00786	0.00786	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisone—psoriatic arthritis	0.00776	0.00776	CcSEcCtD
Vildagliptin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00726	0.00726	CcSEcCtD
Vildagliptin—Weight increased—Prednisone—psoriatic arthritis	0.0072	0.0072	CcSEcCtD
Vildagliptin—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00707	0.00707	CcSEcCtD
Vildagliptin—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00696	0.00696	CcSEcCtD
Vildagliptin—Angioedema—Prednisolone—psoriatic arthritis	0.00694	0.00694	CcSEcCtD
Vildagliptin—Angiopathy—Betamethasone—psoriatic arthritis	0.0066	0.0066	CcSEcCtD
Vildagliptin—Angiopathy—Dexamethasone—psoriatic arthritis	0.0066	0.0066	CcSEcCtD
Vildagliptin—Pancreatitis—Methotrexate—psoriatic arthritis	0.00649	0.00649	CcSEcCtD
Vildagliptin—Angioedema—Triamcinolone—psoriatic arthritis	0.00638	0.00638	CcSEcCtD
Vildagliptin—Angioedema—Methylprednisolone—psoriatic arthritis	0.00636	0.00636	CcSEcCtD
Vildagliptin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Vildagliptin—Oedema—Prednisolone—psoriatic arthritis	0.00619	0.00619	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00615	0.00615	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00599	0.00599	CcSEcCtD
Vildagliptin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00593	0.00593	CcSEcCtD
Vildagliptin—Infestation—Methotrexate—psoriatic arthritis	0.0059	0.0059	CcSEcCtD
Vildagliptin—Infestation NOS—Methotrexate—psoriatic arthritis	0.0059	0.0059	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00589	0.00589	CcSEcCtD
Vildagliptin—Angioedema—Dexamethasone—psoriatic arthritis	0.00579	0.00579	CcSEcCtD
Vildagliptin—Angioedema—Betamethasone—psoriatic arthritis	0.00579	0.00579	CcSEcCtD
Vildagliptin—Angiopathy—Prednisone—psoriatic arthritis	0.00575	0.00575	CcSEcCtD
Vildagliptin—Oedema—Triamcinolone—psoriatic arthritis	0.0057	0.0057	CcSEcCtD
Vildagliptin—Infection—Triamcinolone—psoriatic arthritis	0.00566	0.00566	CcSEcCtD
Vildagliptin—Infection—Methylprednisolone—psoriatic arthritis	0.00565	0.00565	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00558	0.00558	CcSEcCtD
Vildagliptin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00557	0.00557	CcSEcCtD
Vildagliptin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00552	0.00552	CcSEcCtD
Vildagliptin—Malnutrition—Prednisone—psoriatic arthritis	0.00552	0.00552	CcSEcCtD
Vildagliptin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00551	0.00551	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00549	0.00549	CcSEcCtD
Vildagliptin—Hepatitis—Methotrexate—psoriatic arthritis	0.00529	0.00529	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00519	0.00519	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00518	0.00518	CcSEcCtD
Vildagliptin—Oedema—Dexamethasone—psoriatic arthritis	0.00517	0.00517	CcSEcCtD
Vildagliptin—Oedema—Betamethasone—psoriatic arthritis	0.00517	0.00517	CcSEcCtD
Vildagliptin—Infection—Dexamethasone—psoriatic arthritis	0.00513	0.00513	CcSEcCtD
Vildagliptin—Infection—Betamethasone—psoriatic arthritis	0.00513	0.00513	CcSEcCtD
Vildagliptin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00507	0.00507	CcSEcCtD
Vildagliptin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00507	0.00507	CcSEcCtD
Vildagliptin—Angioedema—Prednisone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Vildagliptin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.005	0.005	CcSEcCtD
Vildagliptin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.005	0.005	CcSEcCtD
Vildagliptin—Urticaria—Prednisolone—psoriatic arthritis	0.00492	0.00492	CcSEcCtD
Vildagliptin—Fatigue—Triamcinolone—psoriatic arthritis	0.00491	0.00491	CcSEcCtD
Vildagliptin—Fatigue—Methylprednisolone—psoriatic arthritis	0.0049	0.0049	CcSEcCtD
Vildagliptin—Angiopathy—Methotrexate—psoriatic arthritis	0.0048	0.0048	CcSEcCtD
Vildagliptin—Chills—Methotrexate—psoriatic arthritis	0.00475	0.00475	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00471	0.00471	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00471	0.00471	CcSEcCtD
Vildagliptin—Arthralgia—Prednisone—psoriatic arthritis	0.0047	0.0047	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00466	0.00466	CcSEcCtD
Vildagliptin—Malnutrition—Methotrexate—psoriatic arthritis	0.00461	0.00461	CcSEcCtD
Vildagliptin—Urticaria—Triamcinolone—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Vildagliptin—Urticaria—Methylprednisolone—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Vildagliptin—Oedema—Prednisone—psoriatic arthritis	0.0045	0.0045	CcSEcCtD
Vildagliptin—Infection—Prednisone—psoriatic arthritis	0.00447	0.00447	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Vildagliptin—Fatigue—Dexamethasone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Vildagliptin—Fatigue—Betamethasone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Vildagliptin—Nervous system disorder—Prednisone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Vildagliptin—Skin disorder—Prednisone—psoriatic arthritis	0.00437	0.00437	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00435	0.00435	CcSEcCtD
Vildagliptin—Urticaria—Betamethasone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Vildagliptin—Urticaria—Dexamethasone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.0041	0.0041	CcSEcCtD
Vildagliptin—Dizziness—Prednisolone—psoriatic arthritis	0.0041	0.0041	CcSEcCtD
Vildagliptin—Asthenia—Triamcinolone—psoriatic arthritis	0.00409	0.00409	CcSEcCtD
Vildagliptin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Vildagliptin—Arthralgia—Methotrexate—psoriatic arthritis	0.00392	0.00392	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Vildagliptin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Vildagliptin—Fatigue—Prednisone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Vildagliptin—Headache—Prednisolone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Vildagliptin—Constipation—Prednisone—psoriatic arthritis	0.00385	0.00385	CcSEcCtD
Vildagliptin—Dizziness—Triamcinolone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Vildagliptin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Vildagliptin—Infection—Methotrexate—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Vildagliptin—Asthenia—Betamethasone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Vildagliptin—Asthenia—Dexamethasone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Vildagliptin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00369	0.00369	CcSEcCtD
Vildagliptin—Nausea—Prednisolone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Vildagliptin—Skin disorder—Methotrexate—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Vildagliptin—Urticaria—Prednisone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Vildagliptin—Headache—Triamcinolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Vildagliptin—Headache—Methylprednisolone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Vildagliptin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Vildagliptin—Diarrhoea—Betamethasone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Vildagliptin—Dizziness—Betamethasone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Vildagliptin—Dizziness—Dexamethasone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Vildagliptin—Nausea—Triamcinolone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Vildagliptin—Nausea—Methylprednisolone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Vildagliptin—Fatigue—Methotrexate—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Vildagliptin—Headache—Betamethasone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Vildagliptin—Headache—Dexamethasone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Vildagliptin—Asthenia—Prednisone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Vildagliptin—Diarrhoea—Prednisone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Vildagliptin—Nausea—Dexamethasone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Vildagliptin—Nausea—Betamethasone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Vildagliptin—Urticaria—Methotrexate—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Vildagliptin—Dizziness—Prednisone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Vildagliptin—Headache—Prednisone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Vildagliptin—Asthenia—Methotrexate—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Vildagliptin—Nausea—Prednisone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Vildagliptin—Diarrhoea—Methotrexate—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Vildagliptin—Dizziness—Methotrexate—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Vildagliptin—Headache—Methotrexate—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Vildagliptin—Nausea—Methotrexate—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
